Immunogenic cell death (ICD)-based immunotherapy holds great promise for cancer treatment, but the therapeutic effectiveness of ICD driven by a single death pathway is often limited due to tumor regulatory mechanisms and the immunosuppressive tumor microenviro... ...

请注册登录后继续浏览